На главнуюНовости и политикаПохожее видеоЕще от: MarketInfoResearch.com

US Pharma Market Worth $475 Billion by 2020

Оценок: 2 | Просмотров: 109
The expansion of the insured population, prompted by the introduction of Patient Protection and Affordable Care Act (PPACA), will play a key role in driving US pharmaceutical market revenue up by a third by the end of the decade, says research and consulting firm GlobalData in market report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US" Read more - http://marketinforesearch.com/medical-health-care-other-c-5_339_24/countryfocus-healthcare-regulatory-and-reimbursement-landscape-us-p-18896.html The report forecasts the country's pharmaceutical market value to climb from $359 billion in 2012 to $476 billion in 2020, increasing by 33% over the eight year period. With the PPACA (commonly known as Obamacare) extending health insurance to 32 million more Americans by 2016, patient pools and the demand for drug therapy are expected to increase significantly, driving up healthcare expenditure and pharmaceutical revenue as a result. Like many other countries around the world, the US is expected to experience growth in its elderly population, climbing from a 19% share of all Americans in 2012 to more than 22% by 2020. The expansion of the 60 and over age demographic is another factor that will inevitably drive the US pharmaceuticals industry, owing to the corresponding increase in healthcare demand. GlobalData also expects growth within the US medical devices industry in the near future, with the industry forecast to grow from $139 billion in 2012 to $206 billion in 2020, climbing at a Compound Annual Growth Rate (CAGR) of 5.0%. The US medical equipment industry is one of the largest and most stable in the healthcare industry, accounting for 50% of the global market and consuming approximately 40% of its output. customercare@marketinforesearch.com
Html code for embedding videos on your blog
Текстовые комментарии (0)

Хотите оставить комментарий?

Присоединитесь к YouTube, или войдите, если вы уже зарегистрированы.